Clinical trial
G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers
NCT00082329 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00082329 |
|---|---|
| Title | G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers |
| Official title | Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 Mozobil (Plerixafor) in Healthy Volunteers |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF) |
| Enrollment | 9 |
| Start date | Jun 18, 2004 |
| Primary completion | Oct 25, 2012 |
| Completion | Oct 25, 2012 |
| First posted | May 6, 2004 |
| Last update posted | Jul 22, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: